alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,151–7,175 of 27,380 studies, newest first · page 287 of 1096.

November 2023 25

  1. 2023-11-27

    Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Unique AD-inflammatory biomarker correlations in a community-based cohort reveal a new avenue for utilizing plasma-based biomarkers in the assessment of AD and related dementias. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2023-11-27

    Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Older adults with higher triglyceride levels within the normal to high-normal range had a lower dementia risk and slower cognitive decline over time compared with individuals with lower triglyceride levels. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2023-11-25

    The role of nutrition in the prevention of cognitive decline

    ✓ Peer-reviewed Prevention and risk Current opinion in clinical nutrition and metabolic care

    Key finding: Dementia is a growing concern and underscores the urgent need for effective preventive measures targeting modifiable risk factors.

    Full summary, score breakdown and related studies → Original source

  4. 2023-11-24

    Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol

    ✓ Peer-reviewed Clinical trials BMJ neurology open

    Key finding: GBA-related PD (GBA-PD) patients have higher risk of dementia and reduced survival than non-carriers. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2023-11-24

    Social and Behavior Factors of Alzheimer's Disease and Related Dementias: A National Study in the U.S

    ✓ Peer-reviewed Risk factors American journal of preventive medicine

    Key finding: Lifestyle factors ranked highly in non-disadvantaged counties compared to more environmental factors in disadvantaged counties.

    Full summary, score breakdown and related studies → Original source

  6. 2023-11-23

    A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

    ✓ Peer-reviewed Genetics GeroScience

    Key finding: Walking speed in the placebo group significantly improved across the study duration suggestive of a practice effect but did not change in the NR group (p = 0.0402 and p = 0.4698, respectively). +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2023-11-23

    How to engage patients in computerized cognitive training: a cognitive rehabilitation expert's perspective

    ✓ Peer-reviewed Cognitive tests and assessment Disability and rehabilitation. Assistive technology

    Key finding: Two major themes were identified: (1) facilitating factors and (2) difficulties related to use. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2023-11-23

    Efficacy of smartphone application-based multi-domain cognitive training in older adults without dementia

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in aging neuroscience

    Key finding: Of 101 participants, 85 older adults without dementia (84.1%) who completed the study protocol were included in the statistical analysis. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2023-11-23

    Serum biomarkers associated with aging and neurodegeneration in common marmosets (Callithrix jacchus)

    ✓ Peer-reviewed Biomarkers Neuroscience letters

    Key finding: Aged marmosets (>7 years) had significantly higher GFAP, NfL, UCH-L1, and T-tau than adult marmosets.

    Full summary, score breakdown and related studies → Original source

  10. 2023-11-23

    Imaging of Amyloid-Related Imaging Abnormalities (ARIA)

    ✓ Peer-reviewed Treatments RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

    Key finding: In asymptomatic patients, discontinuation of the drug might be sufficient. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2023-11-22

    [Alzheimer's disease. Current evidence on the preventive role of nutrition]

    ✓ Peer-reviewed Prevention and risk Nutricion hospitalaria

    Key finding: several dietary components have been positively associated with AD prevention, including intake of complex carbohydrates, fiber, omega-3, plant-based proteins, vitamins (folates, choline, vitamin D, C, B6 and B9), zinc, some bioactive compounds such as flavonols and probiotics. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2023-11-22

    Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist

    ✓ Peer-reviewed Genetics Neuron

    Key finding: In the P301S mouse model of tauopathy, ApoE4 increases tau pathology and neurodegeneration when compared with ApoE3 or the absence of ApoE. +1 more finding

    Full summary, score breakdown and related studies → Original source

  13. 2023-11-21

    Five lessons from Alzheimer disease

    ✓ Peer-reviewed Risk factors JAAPA

    Key finding: First, family members bear witness to the behavioral debility, memory decline, and loss of expression associated with Alzheimer disease.

    Full summary, score breakdown and related studies → Original source

  14. 2023-11-20

    A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology medRxiv : the preprint server for health sciences

    Key finding: When seen in isolation, LATE-NC have been associated with a predominantly amnestic profile and slow clinical progression. +3 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

  15. 2023-11-20

    Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: BV estimates for AD plasma biomarkers can potentially refine their clinical and research interpretation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2023-11-20

    Consensus definition of advance care planning in dementia: A 33-country Delphi study

    ✓ Peer-reviewed End-of-life care Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A communication and relationship-centered definitional framework of ACP in dementia evolved through international consensus supporting inclusiveness of persons with dementia and their family.

    Full summary, score breakdown and related studies → Original source

  17. 2023-11-20

    Greater socioenvironmental risk factors and higher chronic pain stage are associated with thinner bilateral temporal lobes

    ✓ Peer-reviewed Risk factors Brain and Behavior

    Key finding: Regression analyses showed that with the inclusion of socioenvironmental factors, the model was significant (p < .001), and sociodemographic (ethnic/race) group differences were not significant (p = .118). +3 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2023-11-19

    Food Insecurity, Race and Ethnicity, and Cognitive Function Among United States Older Adults

    ✓ Peer-reviewed Disparities The Journal of nutrition

    Key finding: Compared with food secure older adults, those reporting food insecurity experienced worsened cognitive functioning over time (B = -0.63, p < .001), and they were more likely to have onset of cognitive impairment (OR= 1.46, p < .001) in the 6-y observation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2023-11-18

    Neurochemical Ameliorating of the Hippocampus in Dyslipidemic Alzheimer Patients Following Silymarin; a Double-Blind Placebo-Controlled Randomized Clinical Trial

    ✓ Peer-reviewed Treatments Medical journal of the Islamic Republic of Iran

    Key finding: Donepezil and silymarin improved lipid profile associated with increased NAA/Cr, and decreased mI/Cr, in AD patients. +3 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2023-11-17

    Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis

    ✓ Peer-reviewed Treatments Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

    Key finding: Anti-amyloid-ß mAbs attenuate cognitive and functional decline compared with placebo in early AD; whether the magnitude of this effect is clinically important remains uncertain, especially relative to the safety profile of these medications. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2023-11-17

    A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: UGOT p-tau217 can be an easily accessible and efficient way to screen and monitor patients with suspected AD pathophysiology, even in the early stages of the continuum.

    Full summary, score breakdown and related studies → Original source

  22. 2023-11-16

    Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: In the Asan cohort, after adjusting for age and sex, p-tau181 (AUC = 0.854) or APOE ε4 status (AUC = 0.769) distinguished Aβ status with high accuracy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2023-11-16

    A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles

    ✓ Peer-reviewed Brain scans and imaging Brain communications

    Key finding: We found 474 relevant peer-reviewed publications, which were organized into the following categories based on their primary focus: typical Alzheimer's disease, mild cognitive impairment and pre-symptomatic populations; atypical Alzheimer's disease; non-Alzheimer's disease neurodegenerative conditions; head-to-head comparisons with other Tau positron emission tomography tracers; and technical considerations.

    Full summary, score breakdown and related studies → Original source

  24. 2023-11-16

    Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity

    ✓ Peer-reviewed Cognitive tests and assessment Neuropsychology

    Key finding: Multiday BRANCH is a feasible, reliable, and valid cognitive measure that may be useful for identifying subtle changes in learning and memory processes in older adults.

    Full summary, score breakdown and related studies → Original source

  25. 2023-11-16

    Explainable AI-based Alzheimer's prediction and management using multimodal data

    ✓ Peer-reviewed Digital health tools PloS one

    Key finding: According to the World Health Organization (WHO), dementia is the seventh leading reason of death among all illnesses and one of the leading causes of disability among the world's elderly people.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →